You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 3, September 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  Ophthalmological Reviews
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

USE OF TYPHOID VACCINE IN CONTINUOUS INTRAVENOUS INFUSION IN TREATMENT OF EYE DISEASES

ROBERTO BUXEDA, M.D.

AMA Arch Ophthalmol. 1952;48(3):352-361.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH the use of typhoid vaccine intravenously in the form of a fairly rapid injection has long been a controversial procedure, it has been a most widely used therapeutic agent in ophthalmology. The use of typhoid vaccine intravenously in a slow continuous infusion is a much more recent procedure. In addition to a review of the literature pertaining to the mechanism of the therapeutic action of typhoid vaccine, this paper describes a method of giving typhoid vaccine intravenously as an infusion and presents case reports to demonstrate the advantages of this method.

Since typhoid vaccine was first used, several investigators, particularly in the United States, have attempted to work out procedures of administration whereby rapid and maximal benefit could be obtained without endangering the patient. Much of this work has been done outside the field of ophthalmology. Typhoid vaccine has been used intravenously in the treatment of systemic diseases for . . . [Full Text PDF of this Article]


Author Affiliations

SAN JUAN, PUERTO RICO

From the Eye Section, Veterans Administration Hospital, Richmond, Va.


Footnotes

Thesis submitted to the Faculty of the Graduate School of Medicine of the University of Pennsylvania, in partial fulfilment of the requirements for the degree of Master of Medical Science (M. Sc. [Med.]) for graduate work in ophthalmology.

Reviewed in the Veterans Administration and published with the approval of the Chief Medical Director. The statements and conclusions published by the author are the result of his own study and do not necessarily reflect the opinion or policy of the Veterans Administration.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.